Study to Investigate the Ability of [11C]Donepezil PET to Image the Parasympathetic Nervous System

Per Borghammer

Status: Completed

Conditions: Parkinson's Disease

Treatments: Other: [11C]donepezil PET

Study type: Observational

Funder types: Other

Identifiers

NCT01877538

01-01

Details and patient eligibility

About

AIM: To validate the tracer [11C]donepezil for use in the parasympathetic nervous system.

MATERIALS AND METHODS: The Investigators will include 7 healthy males aged 45-75 in our study. The participants will receive a careful medical examination, including a neurological examination, as part of the inclusion process. The subjects also have an MRI scan of the brain. PET/CT scans with [11C]donepezil are conducted. Six subjects will receive two PET/CT scans - once for the upper abdominal region and once for the head region two evaluate dynamic binding characteristics of the tracer in internal organ. Additionally, one single subject will receive 5 consecutive whole body PET scans to estimate radioactive dosimetry of this tracer.

PERSPECTIVES: The study will potentially result in the development of a PET ligand for imaging the parasympathetic nervous system. This will have applications for research in Parkinson's disease, diabetes, heart disease and other disorders, in which the autonomic nervous system is involved

Full description

Please see the published paper wherein all details are listed:

In vivo imaging of human acetylcholinesterase density in peripheral organs using 11C-donepezil: dosimetry, biodistribution, and kinetic analyses.

Gjerløff T, Jakobsen S, Nahimi A, Munk OL, Bender D, Alstrup AK, Vase KH, Hansen SB, Brooks DJ, Borghammer P. J Nucl Med. 2014 Nov;55(11):1818-24.

Enrollment: 7 patients

Sex: Male

Ages: 45 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• male
• 45-75 years

Exclusion criteria

• dementia,
• psychiatric diseases,
• serious medical illness including any type of previous cancer, any drug with known interaction with the autonomic nervous system

Trial design

7 participants in 1 patient group

[11C]donepezil PET

Description:

\[11C\]donepezil is a radiopharmaceutical. It is evaluated whether the binding of \[11C\]donepezil in various peripheral tissues is in accordance with known distribution of the parasympathetic nervous system.

Treatment:

Other: [11C]donepezil PET